Barril Alonso, Xavier

Experimental Sciences & Mathematics

Universitat de Barcelona (UB)

Phone 934024557

Email xbarril@ub.edu

Department Departament de Farmàcia i Tecnologia Farmacèutica i Fisicoquímica

Address Av. Joan XXIII 27-31

Keywords

Computer-aided drug design
Structure-based drug discovery
Validation of new therapeutic targets

Short biography Research interests Lines of research Ongoing grants Publications Patents Highlights Conferences & workshops Courses & seminars PhDs, masters & TFGs Dissemination

Short biography

Xavier Barril's research focuses on the discovery of bioactive molecules through a combined use of computational and experimental techniques. His group also develops new computational tools for drug discovery and strives to improve the fundamental understanding of molecular events involved in pharmacological response. Prof. Barril received his Ph.D. from the University of Barcelona (UB) in 2001 for theoretical studies on molecular recognition processes. He then joined Vernalis (Cambridge, UK), where he was involved in a range of drug discovery projects. In 2005 he was appointed ICREA Research Professor and went back to the UB. Prof. Barril has co-authored >90 scientific publications and 13 patents. He is co-founder of Minoryx Therapeutics (2011) and Oniria Therapeutics (2021), as well as part-time CSO of Gain Therapeutics (2018-present).